Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world first-line maintenance Senaparib in advanced ovarian, primary peritoneal, or fallopian tube cancer
ChiCTR2500114880Phase 4Not yet recruiting
- Sponsor
- Henan Provincial People's Hospita,medical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of senaparib in ovarian cancer, primary peritoneal cancer (PPC) and fallopian tube cancer (PFTC), sponsored by Henan Provincial People's Hospita,medical. Primary endpoint: Incidence of adverse reactions. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
senaparib
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on ChiCTR2500114880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114880.